Market News
Stay updated with the latest market trends, earnings, and economic indicators.
L&T, Cummins, Dixon Among Motilal Oswal's Capital Goods Picks; BEL Tops Defence Bet — Full List Inside
Motilal Oswal remains positive on transmission, data centre, and defense-led capex beneficiaries.
ICICI Bank shares in focus after lender receives Sebi’s warning letter. Here's why
ICICI Bank shares are under scrutiny after Sebi issued a warning for a custodian violation related to FPI fund repatriation. Despite this, the bank stated no material impact on its financials. Meanwhile, Motilal Oswal maintains a 'Buy' rating, citing strong growth prospects and a target price of Rs 1,750.
Groww, Lenskart, 9 other stocks among Motilal’s non-Nifty ideas. Check full list
Motilal Oswal has revealed its top non-Nifty stock picks. The brokerage anticipates robust earnings growth for these companies. Key names include ICICI Prudential AMC, TVS Motor, and Dixon Technologies. Delhivery shows the highest projected earnings expansion. Investors can explore these opportunities for potential gains.
Ipca Labs In Focus As Motilal Oswal Remains Bullish After Inline Q4 Results — Check Target Price, Upside
Ipca Labs delivered a steady performance in the March quarter, with Motilal Oswal maintaining its bullish stance, citing strong growth visibility in domestic formulations and export markets.
Asian Paints shares rally 4% after Q4 results. Here’s what Nomura and Motilal Oswal are saying
Asian Paints shares rose sharply after the company reported a 69% year-on-year jump in Q4FY26 profit and stronger margins. While Nomura reiterated its Buy call with a Rs 3,600 target price, Motilal Oswal maintained a Neutral stance, citing demand uncertainties despite raising earnings estimates and growth expectations.
Ashok Leyland Shares In Focus As Motilal Oswal Stays Bullish Despite Near-Term Headwinds — Check Target Price, Upside And More
Ashok Leyland delivered an in-line operational performance for Q4, with Motilal Oswal maintaining a bullish stance on the stock's long-term earnings outlook despite near-term demand uncertainties.
Karur Vysya has a four-pronged plan to move up to the next level: B Ramesh Babu, MD & CEO
After a decade of downsizing the wholesale business, Karur Vysya now plans to reverse it by raising the corporate loan share to 20% in the next two years from 14% at present. It also plans to enter into the credit card business, and loans against mutual funds are on the cards, too, as is a renewed focus on microloans.
Premier Energies shares in focus as promoters sell stake worth Rs 2,289 crore. Check top buyers
Promoter family members of Premier Energies sold shares worth around Rs 2,289 crore through a block deal, while institutional investors, including Quant Mutual Fund and Nomura, picked up stakes. The development comes amid strong investor interest in renewable energy and domestic solar manufacturing, supported by robust earnings growth and aggressive capacity expansion plans.
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
INR rebounds well from historic lows as oil retreats from elevated levels; geopolitical risk and oil price sensitivity to cap upside
The Indian rupee rebounded 49 paise from its all-time closing low to settle at 96.37 against the US dollar on Thursday after crude oil prices retreated from elevated levels amid signs of easing geopolitical friction, alongside likely central bank intervention. Rupee had gained after the recent geopolitical developments, but investors are still gauging the geopolitical risk and oil price sensitivity in the background. The one-year forward market rate for the rupee touched the crucial 100/USD mark on Wednesday, indicating that currency markets are pricing in a weakening bias for the USD/INR pair over the next 12 months. Meanwhile, The Nifty 50 settled at 23,654.70 (down 4.30 points or 0.02%), while the BSE Sensex closed at 75,183.36 (down 135.03 points or 0.18%). The dollar index rose above 99.2 on Thursday, approaching again April-highs, as markets continued to track developments in the Middle East.
Zydus LifeSciences Shares in Focus: Motilal Oswal Maintains Neutral Rating on Limited Upside — Check Revised Target Price
The current valuation provides limited upside and hence, Motilal Oswal has maintained Neutral rating on Zydus Lifesciences.
After Nomura, Motilal Oswal also sees gold duty hike manageable for Titan
Motilal Oswal believes Titan is well-equipped to manage the situation through superior gold sourcing capabilities and a strong balance sheet.